Media Center

Search publications

Our news

All news

Media about us

  • 20 October 2017

    NovaMedica receives a license for production site at its R&D center

    GMP News

    NovaMedica received a license from the FBI SID & GP for a pilot production site at its R&D center. This was announced by Alexander Kuzin, the General Director of the company.

  • 08 September 2017

    New 30-minute STI test allows just one clinic trip

    Helen Clark / Gears of Biz

    A new speedy test will mean that for the first time ever patients with common sexually-transmitted infections will be able to get their diagnosis and treatment in one clinical visit. The test works by placing a swab or a small amount of urine into a test cartridge, which is then inserted into the diagnostic machine, which has been designed by innovation firm Atlas Genetics Ltd.

  • 07 September 2017

    Roche to up Russian Gazyva supply through local fill/finish deal

    Dan Stanton / BioPharma Reporter.com

    Local manufacturer Pharmstandard will make the finished dosage form of Roche’s monoclonal antibody Gazyva (obinutuzumab) at its site in Ufa. The policy has driven most multinationals to sign contracts with domestic drugmakers and invest in local joint ventures. Pfizer broke ground on a facility with NovaMedica in Kaluga in May, GSK formed a JV with Binnopharm in 2011, while AstraZeneca , Novartis and Novo Nordisk have all invested in Russian production facilities.

  • 17 August 2017

    Prostate Cancer: Epic Sciences AR-V7 Test

    OncLive

    Insights From: Emmanuel S. Antonarakis, MBBCh, Johns Hopkins Medicine; Andrew J. Armstrong, MD, MSc, Duke Cancer Center; Howard I. Scher, MD, Memorial Sloan Kettering Cancer Center share their views on the Epic Sciences AR-V7 test in development for prostate cancer.

All publications

Portfolio companies news

All news

In the Spotlight

Read more

Industry news

All news